Search results
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 6 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 6 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 6 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 12 hours ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 14 hours agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 15 hours agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 6 days ago/BioNTech SE. The investment firm, which owns approximately 6.8% of Arbutus, also called for a...
Oracle, Moderna, Palantir Technologies And A Big Bank On CNBC’s ‘Final Trades’ - Oracle (NYSE:ORCL)
Benzinga· 20 hours agoOn CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Oracle Corporation...
3 Blue-Chip Stocks Set to Triple Soon
InvestorPlace· 3 days agoInvestors should have a wide range of companies in multiple sectors within their investment portfolio. Companies with a strong reputation and...
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 3 days agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...